(Q33671901)

28 July 2017

1 reference

title

The health care burden of unstable angina (English)

1 reference

28 July 2017

Kong DF

1

1 reference

28 July 2017

Blazing MA

series ordinal

2

1 reference

28 July 2017

O'Connor CM

series ordinal

3

1 reference

28 July 2017

publication date

1 May 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

247-261

1 reference

Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Natural history of unstable angina with medical or surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Quality of life after bypass surgery for unstable angina. 5-year follow-up results of a Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A method for the detailed assessment of the appropriateness of medical technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Quality of life as an outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Clinical predictors easily obtained at presentation predict resource utilization in unstable angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Measuring heart patients' willingness to pay for changes in angina symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Can improved quality of care reduce the costs of managing angina pectoris?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Medical device therapy for chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Clinical and echocardiographic correlates of health status in patients with acute chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Preinfarctional (unstable) angina--a prospective study--ten year follow-up. Prognostic significance of electrocardiographic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Design of a cost-effectiveness study within a randomized trial: The LIPID trial for secondary prevention of IHD

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effects of mental stress on myocardial ischemia during daily life.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Increased mortality in men with ST segment depression during 24 h ambulatory long-term ECG recording. Results from prospective population study 'Men born in 1914', from Malmö, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Clinical studies of TMR with the CO2 laser

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Implications of cost in treatment selection for patients with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Exercise treadmill score for predicting prognosis in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Coronary bypass grafting economics, including rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Potential economic impact of glycoprotein IIb-IIIa inhibitors in improving outcomes of patients with acute ischemic coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina: Natural history and determinants of prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina. Quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Better functional status in American than Canadian patients with heart disease: an effect of medical care?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina: Angiography, short- and long-term morbidity, mortality and symptomatic status of medically treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Programmed Outcome Research Teams (PORTs) and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Long-term administration of glycoprotein IIb/IIIa antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effectiveness in Health Care

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Direct medical costs of coronary artery disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Coronary risk estimation and treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

PREINFARCTION SYNDROME--MANAGEMENT AND FOLLOW-UP.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Modulation of growth factor action: implications for the treatment of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

The appropriateness of performing coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Acute and subacute coronary insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Gains in life expectancy from medical interventions--standardizing data on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970072-2

7 January 2021

10.1016/S0733-8651(05)70072-2

Identifiers

DOI

1 reference

28 July 2017

1 reference